3rd Annual Manufacturers’ 340B Summit

3rd Annual Manufacturers’ 340B Summit May 16-17, 2019 | Philadelphia, PA www.worldcongress.com/manufacturers340B Join pharmaceutical manufacturers, legal experts, thought leaders, and leading regulatory strategists at World Congress’ 3rd Annual Manufacturers’ 340B Summit, May 16-17, in Philadelphia. This event is your first opportunity of 2019 to ensure you have the internal strategies in place to effectively execute 340B processes. Register with promo code DC200 and save an additional $200 on current early bird rates. How will you benefit from attending? Review the scope of the 340B Program and possible changes to the program Utilize data to identify duplicate discounts and other inconsistencies … Continue reading 3rd Annual Manufacturers’ 340B Summit

Delivering an Enhanced Patient and Prescriber Experience for Personalized Therapies

Today’s guest post comes from Rob Brown, VP/GM of Pharmacy Solutions at McKesson Life Sciences. Rob provides insights on designing patient-centric channel strategies. He also reviews the role of centralized hub services with an integrated specialty pharmacy. Click here to download McKesson’s case study. It describes how an emerging biotech company streamlined access for patients with an acute complex condition. Read on for Rob’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Delivering an Enhanced Patient and Prescriber Experience for Personalized Therapies

Join Me for Asembia’s Specialty Pharmacy Summit 2019

Asembia’s Specialty Pharmacy Summit 2019 April 29 to May 2, 2019 | Las Vegas www.asembiasummit.com Please join me at Asembia’s Specialty Pharmacy Summit 2019 which will take place from April 29 to May 2, 2019 in Las Vegas. This is a must-attend event for anyone connected to specialty pharmacy. You’ll meet an impressive diversity of people from pharmacies, manufacturers, health plans, wholesalers, hospital systems, pharmacy benefit managers, patient advocacy groups, and more. Click here to view the agenda. This year, I will again lead the Featured Session, titled Specialty Pharmacy Industry Outlook: What’s Next? I’ll be joined by Doug Long … Continue reading Join Me for Asembia’s Specialty Pharmacy Summit 2019

CBI’s 5th Annual Formulary, Copay and Access Summit

CBI’s 5th Annual Formulary, Copay and Access Summit April 9-11, 2019 | San Francisco, CA www.cbinet.com/formulary Accumulator programs, state-level copay legislation, formulary exclusions, high-deductible plans, changes in benefit design, NDC blocks, step therapy programs – the challenges continue to arise. This April, the industry comes together to tackle these topics and more at the Formulary, Copay and Access Summit in San Francisco. Visit www.cbinet.com/formulary for further details and to register. Drug Channels readers will save $300 off the standard rate when they use promo code KRA435 and register prior to March 22nd.* Download the agenda here and see in-depth coverage … Continue reading CBI’s 5th Annual Formulary, Copay and Access Summit

CBI’s 4th Edition Drug Pricing Transparency Congress

CBI’s 4th Edition Drug Pricing Transparency Congress March 25-26, 2019 | Philadelphia, PA www.cbinet.com/drugpricing From implementation and changes made across the country in states like Oregon, California and Nevada to the release of the long-awaited HHS proposed rebate rule, complexities continue to arise for industry. According to HHS Secretary Alex Azar, this proposal “has the potential to be the most significant change in how Americans’ drugs are priced at the pharmacy counter, ever.” With all that is going on with drug pricing within state and federal laws, uncertainty arises for stakeholders with responsibilities in commercialization, reimbursement, pricing and compliance practices. … Continue reading CBI’s 4th Edition Drug Pricing Transparency Congress

Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know

Today’s guest post comes from Tim Ogren, Senior Vice President, Products at TrialCard. Tim discusses the rise in pharmacies making fraudulent claims and the costs of these claims. Learn more in Trialcard’s white paper: Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected? TrialCard developed Spotlight®, a pharmacy fraud detection product for manufacturers. To learn more, contact Tim Ogren, TrialCard’s Senior Vice President of Products, at tim.ogren@trialcard.com. Read on for Tim’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal … Continue reading Pharmacy Fraud Within Pharmaceutical Co-Pay Programs: What You Need To Know

Expanded Access Programs 2019

Expanded Access Programs 2019 March 27-28, 2019 | The Inn at Penn | Philadelphia, PA www.cbinet.com/EAP CBI’s Expanded Access Programs 2019 focuses on the design, development and practical implementation of early access programs. The summit convenes top industry stakeholders and regulators to examine current approaches in providing investigational, pre-launch or end-of-lifecycle drugs to patients for treatment purposes. A multi-stakeholder faculty will address key issues affecting EAPs and review the potential impact of the evolving legislative landscape. Drug Channels readers will save $300 off of the standard registration rate when they use code AGK946.* REGISTER TODAY! Join Expert Thought Leaders Including: … Continue reading Expanded Access Programs 2019

Partnering with IDNs BioPharma Strategy Summit West

Partnering with IDNs BioPharma Strategy Summit West March 20-21, 2019 | Scottsdale, AZ www.cbinet.com/IDN As part of an evolving healthcare environment, the life science industry is continually challenged to be effective in how it engages health system partners. It is critical that discussions evolve to meet the needs of today and also where healthcare is headed tomorrow. To address the challenges and opportunities ahead, join a distinguished group of industry pioneers at CBI’s Partnering with IDNs BioPharma Strategy Summit West – an important event for learning how to best meet the needs of these evolving networks for better patient outcomes. … Continue reading Partnering with IDNs BioPharma Strategy Summit West

Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019

Today’s guest post comes from Derek Rago, VP/GM of Data, Evidence & Insights at McKesson Life Sciences. Derek discusses how biopharma companies can use real-world evidence to gain efficiencies and build effective strategies. He also outlines the key elements of an effective data and analytics strategy. To learn more about McKesson’s data, evidence and insights solutions, visit McKesson.com/DataInsights. Read on for Derek’s insights. Read more » Copyright © 2006-2019 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. This Feed is for personal non-commercial use only.          Powered by WPeMatico Continue reading Shaping an Effective Data and Analytics Strategy for Your Oncology Therapy in 2019

CBI’s 15th Annual Life Sciences Accounting & Reporting Congress

CBI’s 15th Annual Life Sciences Accounting & Reporting Congress March 20-22, 2019 | Loews Philadelphia Hotel | Philadelphia, PA www.cbinet.com/accounting As product pricing and contracting within the channel continues to tangle in complexity, and the gross-to-net “bubble” swells in size, leaders in Finance and Accounting are often at the front lines, making decisions around strategy and reporting. CBI’s 15th Annual Life Sciences Accounting & Reporting Congress, the world’s top event for finance, accounting and business leaders within life sciences, provides the in-depth CPE education and networking with nearly 600 professionals. Visit www.cbinet.com/accounting for further details and to register. Drug Channels … Continue reading CBI’s 15th Annual Life Sciences Accounting & Reporting Congress